Cytovale

We can now see sepsis.

San Francisco, United States · Founded 2013 · $191.4M raised

Employees
51–200
Founded
2013
Business Model
B2B
Total Funding
$191.4M
Last Round
$100.0M Series DOct 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Cytovale makes the IntelliSep test, an FDA-cleared in vitro diagnostic that risk-stratifies emergency department patients for sepsis with organ dysfunction by analyzing the biomechanical properties of white blood cells. IntelliSep delivers results in approximately 8 minutes from a small blood sample, enabling faster triage and treatment decisions in a condition where every hour of delay increases mortality by 8%. The test has demonstrated a 42% reduction in mortality and 56% increase in ED discharges in clinical studies.

Summary

Cytovale is a Diagnostics company based in San Francisco, United States, founded in 2013. It has raised $191.4M in total across 3 rounds, most recently a $100.0M Series D round in Oct 2024.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries DOct 2024
$100.0M

Sign up to see all 3 events

Funding: Series B through Series D. Amounts, valuations, and investors where available.

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cytovale on Indexed.vc
<a href="https://indexed.vc/companies/cytovale"><img src="https://indexed.vc/api/badge/company/cytovale" alt="Cytovale on Indexed.vc" width="260" height="76" /></a>